BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21401439)

  • 1. Antipsychotic drug toxicology in children.
    Caccia S; Clavenna A; Bonati M
    Expert Opin Drug Metab Toxicol; 2011 May; 7(5):591-608. PubMed ID: 21401439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment challenges and safety considerations for antipsychotic use in children and adolescents with psychoses.
    McConville BJ; Sorter MT
    J Clin Psychiatry; 2004; 65 Suppl 6():20-9. PubMed ID: 15104523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Off-label second generation antipsychotics for impulse regulation disorders: a review.
    Scheltema Beduin A; de Haan L
    Psychopharmacol Bull; 2010; 43(3):45-81. PubMed ID: 21150846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents.
    Correll CU; Penzner JB; Parikh UH; Mughal T; Javed T; Carbon M; Malhotra AK
    Child Adolesc Psychiatr Clin N Am; 2006 Jan; 15(1):177-206. PubMed ID: 16321730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotics for children and young adults: a comparative effectiveness review.
    Seida JC; Schouten JR; Boylan K; Newton AS; Mousavi SS; Beaith A; Vandermeer B; Dryden DM; Carrey N
    Pediatrics; 2012 Mar; 129(3):e771-84. PubMed ID: 22351885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents.
    Correll CU
    J Clin Psychiatry; 2008; 69 Suppl 4():26-36. PubMed ID: 18533766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.
    Olfson M; Blanco C; Liu L; Moreno C; Laje G
    Arch Gen Psychiatry; 2006 Jun; 63(6):679-85. PubMed ID: 16754841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antipsychotics in children and adolescents.
    Findling RL; Steiner H; Weller EB
    J Clin Psychiatry; 2005; 66 Suppl 7():29-40. PubMed ID: 16124839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-Label Prescribing of Antipsychotics in Adults, Children and Elderly Individuals: A Systematic Review of Recent Prescription Trends.
    Carton L; Cottencin O; Lapeyre-Mestre M; Geoffroy PA; Favre J; Simon N; Bordet R; Rolland B
    Curr Pharm Des; 2015; 21(23):3280-97. PubMed ID: 26088115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of atypical antipsychotic medications in adolescent psychiatric inpatients: a comparison with inpatients who did not receive antipsychotic medications during their stay.
    Pogge DL; Young K; Insalaco B; Harvey PD
    Int J Clin Pract; 2007 Jun; 61(6):896-902. PubMed ID: 17504351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies.
    Verdoux H; Tournier M; Bégaud B
    Acta Psychiatr Scand; 2010 Jan; 121(1):4-10. PubMed ID: 20059452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment-emergent adverse events associated with atypical antipsychotics.
    Cha DS; McIntyre RS
    Expert Opin Pharmacother; 2012 Aug; 13(11):1587-98. PubMed ID: 22304541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Explicit review of risperidone long-acting injection prescribing practice.
    Wheeler A; Vanderpyl J; Carswell C; Stojkovic M; Robinson E
    J Clin Pharm Ther; 2011 Dec; 36(6):651-63. PubMed ID: 22023342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and pharmacokinetics of atypical antipsychotics in children and adolescents.
    Caccia S
    Paediatr Drugs; 2013 Jun; 15(3):217-33. PubMed ID: 23588704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.
    Diatta T; Blazejewski S; Portier A; Lignot S; Quesnot A; Moore N; Fourrier-Réglat A
    Fundam Clin Pharmacol; 2007 Aug; 21(4):371-8. PubMed ID: 17635175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.